Chronotype: what role in the context of gastroenteropancreatic neuroendocrine tumors?

Luigi BarreaGiovanna MuscogiuriGabriella PuglieseRoberta ModicaDaniela LaudisioSara ApranoAntongiulio FaggianoAnnamaria ColaoSilvia Savastano

Published in: Journal of translational medicine (2021)

GEP-NET patients have an unhealthy metabolic profile and present more commonly an evening chronotype. These results support the importance of including the assessment of chronotype in an adjunctive tool for the prevention of metabolic alterations and tumor aggressiveness of GEP-NET.

Keyphrases

neuroendocrine tumors
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported outcomes